Insulin for Type 2 Diabetes: When Is It Used and What to Expect

Yes, Insulin Is Standard for Type 2 Diabetes

Type 2 diabetes is a progressive disease of β-cell decline and insulin resistance. Over time, most people will need insulin—not as "failure," but as physiological replacement.

Key Indications for Insulin Initiation in T2D

  • HbA1c remains above individualized target despite maximal tolerated non-insulin therapy
  • Significant hyperglycemia at diagnosis (HbA1c >10% or symptomatic: polyuria, polydipsia, weight loss)
  • During hospitalization, surgery, glucocorticoid therapy, acute illness
  • Pregnancy or planning pregnancy (insulin = gold standard)
  • Contraindications/intolerance to other glucose-lowering agents (CKD, GI intolerance, hypoglycemia risk, cost)
  • Patient preference (simplicity, avoidance of multiple pills)

Modern Insulin Regimens for T2D

  • Basal Only: Long-acting (glargine, degludec) once daily — simple, low hypoglycemia risk, good starting point.
  • Basal-Bolus: Basal + rapid-acting with meals — physiological, flexible, more injections.
  • Premixed (Biphasic): Fixed ratio (70/30, 75/25) BID — convenient, less flexible.
  • Concentrated Insulins (U200, U300, U500): For high-dose needs (>200 U/day) — less volume, better absorption.

Key Clinical Pearls

  • Starting insulin ≠ failure. It reflects β-cell exhaustion—inevitable in T2D natural history.
  • Combination Therapy: Basal insulin + GLP-1 RA (fixed-ratio or free) or SGLT2 inhibitor → less insulin dose, weight loss, less hypoglycemia, cardiorenal benefits.
  • Regular Monitoring & Titration: SMBG/CGM-guided dose adjustment (e.g., treat-to-target algorithms) essential.
  • Hypoglycemia Education: Recognition, treatment (15-15 rule), glucagon access.
  • Weight Gain Mitigation: Dietitian referral, GLP-1/SGLT2 combo, exercise.

Discussion with Your Provider

If your HbA1c is off-target, ask: "Is it time to consider insulin? What regimen fits my life? Can we combine with newer agents to minimize dose/side effects?" Shared decision-making optimizes outcomes.

Diabetes - Related Articles